
Get Zepbound® Online.Found gives you a plan.
Zepbound (tirzepatide) is an FDA-approved weekly injection that targets two hunger hormones, GLP-1 and GIP, to reduce appetite and support lasting weight loss. In clinical trials, people lost an average of 20% of their body weight in one year. Found’s board-certified obesity medicine clinicians check your insurance, write your prescription if you qualify, and build a plan around your life.
Does your insurance cover Zepbound? We'll check
Covered by most major insurance plans. With insurance and the Lilly savings card, members can pay as little as $25/month for medication
Most places give you a prescription.Found gives you a plan.
Anyone can write a GLP-1 script. What makes the difference is what happens around it. You get a clinician who knows your history, dose that adjusts as you change, and support that doesn't disappear after month one.
Medication

Zepbound® Pen
from $
25
/mo
One weekly shot · one pen a week

Zepbound® Kwik Pen
from $
299
/mo
One weekly shot · one pen a week
+
=
Total cost
from $
74
/mo
with
insurance
Data sourced from published clinical trials. Individual results vary.
Your Found provider recommends the medication best matched to your biology and goals.
Clinical results. Real numbers.
Lose up to 20% in a year*
In the SURMOUNT-1 trial, people taking Zepbound lost an average of 48 lbs over 72 weeks — vs. 7 lbs on placebo.
*For members prescribed Zepbound. Average weight loss in one year is 20% (vs. 3.1% with diet and exercise alone). Based on a 72-week clinical trial of the highest dose in non-diabetic patients with obesity, paired with healthy lifestyle changes. Individual results may vary.
How do they compare?
We're not going to tell you Zepbound is right for everyone. Here's what the clinical data shows — including the 2025 SURMOUNT-5 head-to-head trial — so you can stop Googling and just know.
Zepbound®
Avg. weight loss
~
20.9
%
Active ingredient
Tirzepatide
format available
Pen and KwikPen
FDA approval
Yes
FDA-approved for
Moderate-to-severe obstructive sleep apnea
Wegovy®
Avg. weight loss
~
15
%
Active ingredient
Semaglutide
format available
Pen or Pills
FDA approval
Yes
FDA-approved for
Reducing risk of heart attack, stroke, and cardiovascular death in adults with existing heart disease
Data sourced from published clinical trials. Individual results vary.
Your Found provider recommends the medication best matched to your biology and goals.
Who is Zepbound right for?
Zepbound is FDA-approved for adults with a BMI of 30+, or 27+ with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol).
- You've tried lifestyle changes without lasting results
- You meet BMI criteria with no contraindications (your provider confirms)
- You prefer an auto-injector pen over drawing your own dose
- You have insurance coverage for Zepbound
- You're worried about side effects, or experienced them with semaglutide (Wegovy/Ozempic)
- You want the least expensive option
- You want to avoid weekly injections entirely
- Personal or family history of MTC (medullary thyroid carcinoma) or MEN2
- Severe GI conditions, history of pancreatitis, or insulin-dependent diabetes
- You're pregnant or planning to become pregnant
Your Found provider reviews your full health history before prescribing anything.











